8 April 2021 - Deborah Wilkes
Premium
New Zealand’s AFT Pharmaceuticals has signed a licensing agreement for its Maxigesic combination painkiller with Polish company Mercapharm. The company has also revised its financial guidance following delays and disruptions related to the COVID-19 pandemic.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.